In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits
- 15 January 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (2), 230-235
- https://doi.org/10.1161/hc0202.101988
Abstract
Background— Patients with hypertrophic obstructive cardiomyopathy have left ventricular (LV) diastolic dysfunction due, in part, to temporal heterogeneity in regional function. The acute effect of the relief of LV outflow tract obstruction is unknown. Therefore, we investigated the effects of nonsurgical septal reduction therapy (NSRT) on regional function.Keywords
This publication has 18 references indexed in Scilit:
- Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USPJournal of Controlled Release, 1998
- Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effectJournal of Controlled Release, 1997
- Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materialsJournal of Controlled Release, 1996
- Comparison of Poly(DL-Lactide-co-Glycolide) and Polystyrene Microsphere Targeting to Intestinal M CellsJournal of Drug Targeting, 1993
- Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF)Journal of Controlled Release, 1992
- Nanocapsules as carriers for oral peptide deliveryJournal of Controlled Release, 1990
- Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestineBiology of the Cell, 1987
- Pharmacokinetics and distribution of a biodegradable drug-carrierInternational Journal of Pharmaceutics, 1983
- Oral administration of liposomally-entrapped heparin to beagle dogs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976